12:00 AM
 | 
Sep 27, 2010
 |  BC Week In Review  |  Clinical News  |  Regulatory

Abilify aripiprazole regulatory update

Otsuka Pharmaceutical Co. Ltd., Tokyo, Japan
Bristol-Myers Squibb Co. (NYSE:BMY), New York, N.Y.
Merck & Co. Inc. (NYSE:MRK), Whitehouse Station, N.J.
Product: Abilify aripiprazole; Cardiolite; Coumadin warfarin; Orencia...

Read the full 170 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >